Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,355.00
Bid: 2,360.00
Ask: 2,361.00
Change: -16.00 (-0.67%)
Spread: 1.00 (0.042%)
Open: 2,371.00
High: 2,386.00
Low: 2,355.00
Prev. Close: 2,371.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US Bond Issue by B.A.T Capital Corporation

4 Sep 2019 07:00

RNS Number : 1196L
British American Tobacco PLC
04 September 2019
 

4 September 2019

 

British American Tobacco Announces Pricing of $3,500,000,000 Notes Offering

 

British American Tobacco p.l.c. ("BAT") today announces that B.A.T Capital Corporation (the "Issuer"), a wholly owned subsidiary of BAT, has priced an offering of $3,500,000,000 aggregate principal amount of guaranteed debt securities, consisting of (1) $1,000,000,000 2.789% Notes due 2024; (2) $1,000,000,000 3.215% Notes due 2026; (3) $500,000,000 3.462% Notes due 2029; and (4) $1,000,000,000 4.758% Notes due 2049 (collectively, the "Notes"). The issuance is expected to close on 6 September 2019, subject to customary closing conditions.

The Notes will be fully and unconditionally guaranteed on a senior and unsecured and joint and several basis by BAT, B.A.T. Netherlands Finance B.V., B.A.T. International Finance p.l.c. and Reynolds American Inc. (together, the "Guarantors").

BAT intends to use the net proceeds of the offering of the Notes to refinance upcoming maturities, to potentially redeem prior to maturity some of the BAT Group's bonds and for general corporate purposes.

BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc. are acting as joint book-running managers for the proposed offering.

The offering of the Notes will be made under BAT's existing effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"), which is available online at www.sec.gov. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering and other information relating to the Issuer and the Guarantors have been filed with the SEC. The shelf registration statement, the preliminary prospectus supplement and the accompanying prospectus may be obtained, free of charge, by contacting BofA Securities, Inc. at +1 800 294 1322, Barclays Capital Inc. at +1 888 603 5847, Citigroup Global Markets Inc. at +1 800 831 9146, Deutsche Bank Securities Inc. at +1 866 811 8049, or HSBC Securities (USA) Inc. at +1 866 811 8049.

The preliminary prospectus supplement is also available at:

https://www.sec.gov/Archives/edgar/data/1275283/000119312519236042/d770456d424b5.htm 

The shelf registration statement is also available at:

https://www.sec.gov/Archives/edgar/data/1275283/000119312519195742/d776937df3asr.htm

 

This communication shall not constitute an offer to sell nor a solicitation of an offer to buy the Notes. This offering is being made only pursuant to the Form F-3 registration statement, the prospectus supplement and the accompanying prospectus and only to such persons and in such jurisdictions as is permitted under applicable law.

Enquiries:

 

Investor Relations

Mike Nightingale / Rachael Brierley / John Harney

+44 (0)20 7845 1180 / 1519 / 1263

 

Press Office

+44 (0)20 7845 2888 (24 hours) | @BATPress 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUOSARKWAKRUR
Date   Source Headline
4th Dec 20239:24 amRNSDirectorate Change
24th Nov 20232:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information
14th Sep 20239:00 amRNSRussia business update - sale completed
12th Sep 20233:05 pmRNSDirector/PDMR Shareholding
7th Sep 20231:15 pmRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSRussia business update – agreement signed
1st Sep 202310:30 amRNSTotal Voting Rights
24th Aug 20233:40 pmRNSDirector/PDMR Shareholding
22nd Aug 20234:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20233:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:25 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:20 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:15 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSCompany Secretary Change
14th Aug 20234:53 pmRNSTender Offer Pricing
14th Aug 202311:30 amRNSResult of Tender Offer
3rd Aug 20233:30 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:20 amRNSPublication of Supplementary Prospectus
1st Aug 202311:38 amRNSPricing Notes Offering
1st Aug 202310:35 amRNSTotal Voting Rights
31st Jul 20231:26 pmRNSTender Offer
26th Jul 20237:00 amRNSHalf-year Report
6th Jul 20233:00 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSBranch Register: Dividend Finalisation Information
3rd Jul 20231:40 pmRNSBlock listing Interim Review
3rd Jul 20231:30 pmRNSTotal Voting Rights
20th Jun 202311:00 amRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSManagement Board Changes
8th Jun 202312:45 pmRNSDirector/PDMR Shareholding
6th Jun 202310:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNS2023 First Half Pre-Close Trading Update
1st Jun 202311:00 amRNSTotal Voting Rights
31st May 202310:45 amRNSDirector/PDMR Shareholding
24th May 20234:35 pmRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSHolding(s) in Company
15th May 20237:00 amRNSBAT announces Tadeu Marroco as Chief Executive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.